LEADER 04712nam  2200625Ia 450 
001 9910814402003321
005 20240410164725.0
010   $a1-61942-712-5
035   $a(CKB)2550000001040705
035   $a(EBL)3017894
035   $a(SSID)ssj0000875843
035   $a(PQKBManifestationID)11504282
035   $a(PQKBTitleCode)TC0000875843
035   $a(PQKBWorkID)10896223
035   $a(PQKB)11418645
035   $a(MiAaPQ)EBC3017894
035   $a(Au-PeEL)EBL3017894
035   $a(CaPaEBR)ebr10654865
035   $a(OCoLC)923654218
035   $a(EXLCZ)992550000001040705
100   $a20111102d2012      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aProbiotics$b[electronic resource] $esources, types and health benefits /$fAbbey Smith and Caleb L. Jones, editors
205   $a1st ed.
210   $aHauppauge, NY $cNova Science Publishers$dc2012
215   $a1 online resource (273 p.)
225 0 $aMicrobiology research advances
300   $aDescription based upon print version of record.
311   $a1-61942-691-9 
320   $aIncludes bibliographical references and index.
327   $a""PROBIOTICS ""; ""PROBIOTICS ""; ""CONTENTS""; ""PREFACE ""; ""ROLE OF PROBIOTICS AND DIETARY FIBRE  IN MAINTAINING HEALTHY GUT FLORA  ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""CONCEPT OF FIBRE""; ""DEVELOPMENT AND EVOLUTION  OF FIBRE DETERMINATION METHODS ""; ""CLASSIFICATION OF DIETARY FIBRE ""; ""RICE ""; ""SOLUBLE AND INSOLUBLE FIBRE IN RICE  ""; ""PHYSIOLOGICAL AND METABOLIC EFFECTS OF  DIETARY FIBRE ON HUMAN HEALTH""; ""Daily Intake of Dietary Fibre ""; ""Fermentation of Dietary Fibre ""; ""Why In-Vitro Fermentation?""; ""LIMITATIONS AND IMPORTANCE OF IN-VITRO FERMENTATION ""
327   $a""IN-VITRO FERMENTATION MODELS """"PRODUCTS FROM THE FERMENTATION OF DIETARY FIBRE ""; ""SHORT CHAIN FATTY ACIDS AND THEIR IMPLICATIONS ""; ""FACTORS INFLUENCING SCFA FORMATION DURING FERMENTATION ""; ""CONCEPT OF PREBIOTIC, PROBIOTIC, AND SYMBIOTIC ""; ""COLONIC FOOD AND PREBIOTICS ""; ""CURRENT PROBIOTIC POSITION AND STATE OF THE ART ""; ""Lactobacillus Species ""; ""BIFIDOBACTERIUM SPECIES""; ""CONCEPT OF SYMBIOTIC ""; ""STRATEGY FOR ACETATE, PROPIONATE AND BUTYRATE FORMATION BY BIFIDOBACTERIA AND LACTOBACILLUS SPECIES""; ""MICROBIAL ADHESION ""; ""CONCLUSION ""; ""REFERENCES ""
327   $a""PORCINE TOLL-LIKE RECEPTORS AND THEIR CROSSTALK WITH IMMUNOBIOTICS:  IMPACT IN THE REGULATION OF GUT  INFLAMMATORY IMMUNITY""""ABSTRACT ""; ""INTRODUCTION ""; ""THE INNATE IMMUNE SYSTEM IN THE GUT: ROLE OF TOLL-LIKE RECEPTORS IN INNATE IMMUNITY AND TOLERANCE ""; ""IMMUNOREGULATORY EFFECT OF LACTIC ACID BACTERIA  IN INTESTINAL INNATE IMMUNITY VIA  PATTERN RECOGNITION RECEPTORS ""; ""FUNCTIONAL EXPRESSION OF TLRS IN SWINE GUT-ASSOCIATED LYMPHOID TISSUES (GALT) ""; ""CONSTRUCTION OF MOLECULAR IMMUNOASSAY SYSTEM FOR  THE DISCOVERY OF NOVEL IMMUNOBIOTICS AND IMMUNOGENICS ""
327   $a""UTILIZATION OF PORCINE INTESTINAL EPITHELIAL CELLS  FOR SELECTION AND STUDY OF IMMUNOBIOTICS """"Modulation of TLR4-Mediated Inflammatory Response in PIE Cells by Immunobiotics ""; ""Modulation of TLR3-Mediated Anti-Viral Inflammatory Response in PIE Cells by Immunobiotics ""; ""CONCLUSION ""; ""ACKNOWLEDGMENTS ""; ""REFERENCES ""; ""LACTOBACILLUS PLANTARUM: FUNCTIONAL CHARACTERISTICS FOR PROBIOTIC APPLICATIONS ""; ""ABSTRACT""; ""INTRODUCTION ""; ""FUNCTIONAL PROPERTIES ""; ""HEALTH BENEFITS AND THERAPEUTIC EFFECTS""; ""FOOD AND PHARMACEUTICAL APPLICATIONS ""; ""CONCLUSION ""
327   $a""REFERENCES """"PROBIOTICS IN THE PREVENTION AND TREATMENT OF ELDERLY DISEASE ""; ""ABSTRACT""; ""INTRODUCTION ""; ""AGE-RELATED ALTERATIONS IN THE INTESTINAL MICROBIOTA ""; ""AGE-RELATED ALTERATIONS IN COLONIC METABOLIC ACTIVITY ""; ""PROBIOTICS IN THE PREVENTION AND TREATMENT  OF ELDERLY DISEASE ""; ""APPENDIX I. PUBLISHED LITERATURE FOCUSED ON THE USE OF PROBIOTICS IN ELDERLY DISEASE  ""; ""1) Gut Microecology""; ""2) Bowel Movement, Constipation, and Gut transit Time ""; ""3) Irritable Bowel Syndrome ""; ""4) Antibiotic-associated Diarrhea (AAD) ""; ""5) Bacterial Vaginosis (BV) ""
327   $a""6) Immune Modulation ""
410  0$aMicrobiology Research Advances
606   $aProbiotics
606   $aProbiotics$xTherapeutic use
615  0$aProbiotics.
615  0$aProbiotics$xTherapeutic use.
676   $a615.3/29
701   $aSmith$b Abbey$01633474
701   $aJones$b Caleb L$01633475
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910814402003321
996   $aProbiotics$93973236
997   $aUNINA